You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

sorafenib

Showing 51 - 75 of 320
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • HAIC
  • +8 more
  • Quanzhou, Fujian, China
  • +1 more
Jan 26, 2023

Hepatocellular Carcinoma, Hepatoma, Liver Cell Carcinoma Trial in United States (DEB-TACE, Sorafenib)

Terminated
Has Results
  • Hepatocellular Carcinoma
  • +2 more
  • DEB-TACE
  • Sorafenib
  • Birmingham, Alabama
  • +5 more
Jan 25, 2021

Thyroid Cancer, Thyroid Cancer, Medullary, Differentiated Thyroid Cancer Trial in Tampa (Lenvatinib, Sorafenib, Cabozantinib)

Terminated
Has Results
  • Thyroid Cancer
  • +5 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jul 12, 2021

Liver Metastasis, Cancer Trial in Toronto (Sorafenib)

Completed
  • Liver Metastasis
  • Cancer
  • Sorafenib
  • Toronto, Ontario, Canada
    University Health Network
Sep 8, 2020

Carcinoma, Hepatocellular Trial in China, Korea, Republic of, Taiwan (Tepotinib 300 mg, Tepotinib 500 mg, Tepotinib 1000 mg)

Completed
Has Results
  • Carcinoma, Hepatocellular
  • Tepotinib 300 mg
  • +4 more
  • Beijing, Beijing, China
  • +42 more
Aug 22, 2022

Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • TACE
  • +8 more
  • Quanzhou, Fujian, China
  • +3 more
Jan 29, 2023

Hepatocellular Carcinoma Trial in Worldwide (PDR001, Sorafenib)

Completed
  • Hepatocellular Carcinoma
  • Detroit, Michigan
  • +8 more
Dec 16, 2020

Lung Cancer Trial in New Haven, Houston (Erlotinib, AZD6244, MK-2206)

Completed
Has Results
  • Lung Cancer
  • New Haven, Connecticut
  • +1 more
Dec 14, 2021

Hepatocellular Cancer Trial in Boston (Sorafenib, radiofrequency ablation)

Completed
Has Results
  • Hepatocellular Cancer
  • Sorafenib
  • radiofrequency ablation
  • Boston, Massachusetts
  • +1 more
Sep 10, 2020

Sarcoma Trial in Los Angeles (sorafenib, Ifosfamide)

Terminated
Has Results
  • Sarcoma
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Jul 29, 2020

Unresectable Hepatocellular Carcinoma, Portal Vein Thrombosis Trial in Hangzhou (SBRT+TACE+Sorafenib, Sorafenib)

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • Portal Vein Thrombosis
  • SBRT+TACE+Sorafenib
  • Sorafenib
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
Jun 15, 2020

Advanced Hepatocellular Carcinoma (HCC) Trial in Beijing (camrelizumab;Rivoceranib, Rivoceranib, Sorafenib)

Enrolling by invitation
  • Advanced Hepatocellular Carcinoma (HCC)
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Oct 21, 2021

Cancer, Advanced Solid Tumors Trial in Amsterdam (Sunitinib, Sorafenib, Erlotinib)

Completed
  • Cancer
  • Advanced Solid Tumors
  • Amsterdam, Netherlands
    VUMedical Center
Apr 14, 2021

Hepatocellular Carcinoma Trial in Birmingham, Cleveland, Houston (Carotuximab (TRC105), Sorafenib)

Completed
Has Results
  • Hepatocellular Carcinoma
  • Carotuximab (TRC105)
  • Sorafenib
  • Birmingham, Alabama
  • +2 more
Jul 2, 2020

Carcinoma, Hepatocellular, Secondary Trial in Hong Kong (Sorafenib, Capecitabine, Oxaliplatin)

Completed
  • Carcinoma, Hepatocellular
  • Secondary
  • Sorafenib
  • +2 more
  • Hong Kong, Hong Kong
    Queen Mary Hospital
Apr 9, 2020

Hepatocellular Carcinoma Trial in Guangzhou (Sorafenib, Transarterial chemoembolization)

Recruiting
  • Hepatocellular Carcinoma
  • Sorafenib
  • Transarterial chemoembolization
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Mar 23, 2020

Hepatocellular Carcinoma Trial in Worldwide (TheraSphere®, Sorafenib)

Terminated
Has Results
  • Hepatocellular Carcinoma
  • TheraSphere®
  • Sorafenib
  • Chicago, Illinois
  • +18 more
Apr 19, 2021

HepatoCellular Carcinoma, Unresectable HepatoCellular Carcinoma, Liver Cancer Trial in Tampa (Stereotactic Body Radiation

Withdrawn
  • HepatoCellular Carcinoma
  • +2 more
  • Stereotactic Body Radiation Therapy (SBRT)
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jun 3, 2020

Hepatocellular Cancer Trial in Boston (Leucovorin, Fluorouracil, Oxaliplatin)

Completed
Has Results
  • Hepatocellular Cancer
  • Boston, Massachusetts
  • +2 more
Apr 21, 2020

Carcinoma, Hepatocellular, Neuroendocrine Tumors Trial in Aarhus (Sorafenib, Radiofrequency ablation (RFA) or surgery,

Completed
  • Carcinoma, Hepatocellular
  • Neuroendocrine Tumors
  • Sorafenib
  • +3 more
  • Aarhus, Aarhus C, Denmark
    Department of Hepatology and Gastroenterology
Apr 27, 2021

Advanced Cancer Trial in Houston (Bevacizumab, Sorafenib, Erlotinib)

Completed
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 27, 2020

Solid Tumors, Advanced Cancer Trial in Houston (Anastrozole, Bevacizumab, Everolimus)

Completed
  • Solid Tumors
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 20, 2021

Carcinoma, Hepatocellular Trial in Worldwide (Atezolizumab, Bevacizumab, Sorafenib)

Active, not recruiting
Has Results
  • Carcinoma, Hepatocellular
  • Phoenix, Arizona
  • +118 more
Jun 14, 2022

AML, FLT3-ITD Mutation Trial in Hong Kong (Sorafenib, Omacetaxine Mepesuccinate Injection)

Completed
  • AML
  • FLT3-ITD Mutation
  • Sorafenib
  • Omacetaxine Mepesuccinate Injection
  • Hong Kong, Hong Kong
    The University of Hong Kong
Mar 26, 2020

Leukemia, Acute Myeloid Leukemia Trial in Houston (Selinexor, Sorafenib)

Completed
Has Results
  • Leukemia
  • Acute Myeloid Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 18, 2020